Switching Rabbits to Nobivac^® Myxo-RHD PLUS

Nobivac Myxo-RHD PLUS will be replacing Nobivac Myxo-RHD, which will no longer be available once all current stock has been exhausted.

Nobivac Myxo-RHD PLUS has proven efficacy in naïve rabbits and effectively boosts rabbits previously vaccinated against myxomatosis, RHDV-1 and RHDV-2. However, please note that Nobivac Myxo-RHD PLUS vaccine product labelling also includes the following statement:

Rabbits that have been vaccinated previously with another myxomatosis vaccine, or that have experienced natural myxomatosis infection in the field, may not develop an adequate immune response against rabbit haemorrhagic disease following vaccination.

This statement relates to the phenomenon of vector interference which is very relevant to a very specific subset of rabbits being switched over to the new vaccine. Based on the results of efficacy and switching studies, an optimum approach to avoid this potential risk is laid out below:

Annual boosters for all groups of rabbits in subsequent years can be managed successfully with Nobivac Myxo-RHD PLUS.

Nobivac^® Myxo-RHD PLUS contains live myxoma vectored RHD virus strain 009 and MK 1898. POM-V
MSD Animal Health UK Limited. Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942.
Further information is available from the SPC, Datasheet or package leaflet. Advice should be sought from the medicine prescriber.
Use medicines responsibly